CARTIFAN-1: Concerning fatal adverse events with global use of chimeric antigen receptor-T-cell therapy in multiple myeloma

被引：4
|
作者：
Hadidi, Samer Al [1 ,3 ]
Cliff, Edward R. S. [2 ]
机构：
[1] Univ Arkansas Med Sci, Winthrop P Rockefeller Canc Inst, Myeloma Ctr, Little Rock, AR USA
[2] Harvard Med Sch, Brigham & Womens Hosp, Program Regulat Therapeut & Law, Boston, MA USA
[3] Univ Arkansas Med Sci, Myeloma Ctr, Winthrop P Rock efeller Canc Inst, Little Rock, AR 72205 USA
来源：
EUROPEAN JOURNAL OF CANCER | 2023年 / 182卷
关键词：
D O I：
10.1016/j.ejca.2022.12.018
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1 / 2
页数：2
相关论文
共 50 条
  • [41] Adverse events associated with chimeric antigen receptor T-cell therapy in ophthalmology: a narrative review
    Sarwar, Sara
    Riaz, Unood
    Ali, Abraish
    Kailash, Sejal Jain
    ANNALS OF MEDICINE AND SURGERY, 2024, 86 (07): : 4035 - 4041
  • [42] Paving the road to make chimeric antigen receptor-T-cell therapy effective against solid tumors
    Adachi, Keishi
    Tamada, Koji
    CANCER SCIENCE, 2022, 113 (12) : 4020 - 4029
  • [43] Advances in the development of chimeric antigen receptor-T-cell therapy in B-cell acute lymphoblastic leukemia
    Zhang Xian
    Li Jing-Jing
    Lu Pei-Hua
    中华医学杂志英文版, 2020, 133 (04) : 474 - 482
  • [44] SAFETY AND MANAGEMENT OF ADVERSE EVENTS WITH CILTACABTAGENE AUTOLEUCEL, A CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: INITIAL RESULTS FROM CARTITUDE-1
    Florendo, Erika
    Wilmoth, Jenai
    Romanov, Vadim
    Garrett, Ahsraf
    Martin, Thomas
    Madduri, Deepu
    ONCOLOGY NURSING FORUM, 2021, 48 (02)
  • [45] Nursing Care Throughout the Chimeric Antigen Receptor T-Cell Therapy Process for Multiple Myeloma
    Steinbach, Mary
    Zitella, Laura J.
    Florendo, Erika
    Lee, Erin
    Riccobono, Carrie
    DiFilippo, Heather
    Aronson, Elizabeth
    SEMINARS IN ONCOLOGY NURSING, 2023, 39 (06)
  • [46] Management of bone disease with concurrent chimeric antigen receptor T-cell therapy for multiple myeloma
    Kuruvilla, Davis
    Huynh, Thien
    Nester, Matthew
    Chose, Chloe
    Zervoudakis, Guston
    Letson, G. Douglas
    Joyce, David M.
    Binitie, Odion T.
    Figura, Nicholas B.
    Costello, James R.
    Freeman, Ciara L.
    Lazarides, Alexander L.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2024, 201
  • [47] Clinical data, limitations and perspectives on chimeric antigen receptor T-cell therapy in multiple myeloma
    Beauvais, David
    Danhof, Sophia
    Hayden, Patrick J.
    Einsele, Hermann
    Yakoub-Agha, Ibrahim
    CURRENT OPINION IN ONCOLOGY, 2020, 32 (05) : 418 - 426
  • [48] BCMA-targeting chimeric antigen receptor T cell therapy for relapsed and/or refractory multiple myeloma
    Fang, Jiamin
    Zhou, Fuling
    ANNALS OF HEMATOLOGY, 2024, 103 (04) : 1069 - 1083
  • [49] Chimeric Antigen Receptor T-Cell and Bispecific Antibody Therapy in Multiple Myeloma: Moving Into the Future
    Holstein, Sarah A.
    Grant, Shakira J.
    Wildes, Tanya M.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (27) : 4416 - +
  • [50] Chimeric Antigen Receptor T-Cell Therapy in Multiple Myeloma-Challenges and Potential Solutions
    Al Hadidi, Samer
    Zangari, Maurizio
    van Rhee, Frits
    JAMA ONCOLOGY, 2022, 8 (06) : 823 - 824
12345